Corient Private Wealth
CRL icon

Corient Private Wealth’s Charles River Laboratories CRL Stock Holding History

Corient Private Wealth’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.08M Sell
13,579
-4,183
-24% -$745K ﹤0.01% 1107
2026
Q1 		$3.02M Buy
17,762
+134
+0.8% +$24.8K ﹤0.01% 1051
2025
Q4 		$3.52M Buy
17,628
+7,166
+68% +$1.3M ﹤0.01% 897
2025
Q3 		$1.64M Sell
10,462
-1,363
-12% -$216K ﹤0.01% 1162
2025
Q2 		$1.79M Buy
11,825
+6,669
+129% +$889K ﹤0.01% 1083
2025
Q1 		$776K Sell
5,156
-2,926
-36% -$491K ﹤0.01% 1390
2024
Q4 		$1.49M Sell
8,082
-3,876
-32% -$747K ﹤0.01% 1124
2024
Q3 		$2.36M Sell
11,958
-328
-3% -$68.2K ﹤0.01% 1025
2024
Q2 		$2.54M Buy
12,286
+2
+0% +$453 ﹤0.01% 929
2024
Q1 		$3.33M Sell
12,284
-1,074
-8% -$256K 0.01% 821
2023
Q4 		$3.16M Buy
13,358
+7,127
+114% +$1.4M 0.01% 829
2023
Q3 		$1.22M Buy
6,231
+2,713
+77% +$557K ﹤0.01% 1123
2023
Q2 		$740K Buy
3,518
+372
+12% +$74K ﹤0.01% 1266
2023
Q1 		$635K Buy
3,146
+316
+11% +$71.6K ﹤0.01% 1280
2022
Q4 		$617K Buy
+2,830
New +$618K ﹤0.01% 1075

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Corient Private Wealth's CRL Position: Q2 2026 in Review

Corient Private Wealth reduced its Charles River Laboratories (CRL) stake by 24% in Q2 2026, selling an estimated $745K and leaving 13,579 shares worth $3.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1107.

Corient Private Wealth first reported a position in CRL in Q4 2022 and has held it in 15 quarters since. The position peaked at $3.52M in Q4 2025. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Corient Private Wealth held 13,579 shares of Charles River Laboratories worth $3.08M as of Q2 2026.
  • Corient Private Wealth sold 4,183 Charles River Laboratories shares in Q2 2026, an estimated $745K.
  • Charles River Laboratories made up ﹤0.01% of Corient Private Wealth's portfolio in Q2 2026, its #1107 holding.
  • Corient Private Wealth first reported a position in Charles River Laboratories in Q4 2022 and has held it in 15 quarters since.
  • Corient Private Wealth's Charles River Laboratories position peaked at $3.52M in Q4 2025.
  • 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Corient Private Wealth's 13F filing for Q2 2026, filed 12 Aug 2026.